Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange Detected403 Forbidden page is shown in place of the study record, removing access to the study details and related sections. This indicates the page is now restricted to access.SummaryDifference17%

- Check50 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update. No study details, eligibility criteria, or other user-facing content were modified.SummaryDifference0.1%

- Check71 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing the previous v3.6.4; this indicates a small site update and does not change the study information displayed on the page.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a minor maintenance update with no changes to study content or data visible on the page.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.